MELANOMA RECURRENT
Clinical trials for MELANOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new MELANOMA RECURRENT trials appear
Sign up with your email to follow new studies for MELANOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for patients with Hard-to-Treat cancers
Disease control OngoingThis study is testing a new drug called ST101 for people with advanced solid tumors that have not responded to other treatments. The main goals are to find a safe dose and see if the drug can help control cancers like glioblastoma, melanoma, breast cancer, and prostate cancer. Th…
Matched conditions: MELANOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Brazilian trial challenges standard: can one year of treatment match two?
Disease control OngoingThis study is testing if a shorter, one-year course of pembrolizumab immunotherapy works as well as the standard two-year course for people with advanced melanoma that has spread or returned. It aims to make this effective treatment more accessible and affordable within Brazil's …
Matched conditions: MELANOMA RECURRENT
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for Tough-to-Treat skin cancer: experimental combo targets immune system
Disease control OngoingThis early-stage trial is testing a new three-drug combination for people with advanced melanoma that has spread or cannot be removed by surgery and has worsened after standard immunotherapy. The study aims to find a safe and effective dose of the experimental drug BI-1607 when g…
Matched conditions: MELANOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC